Another interesting study found that HIF1α is abnormally overexpressed in AML, functioning as an oncogene by activating DNMT 3α, leading to DNA hypermethylation and promoting the expression of WTAP, a key component of the m6A MTC, thereby driving AML progression. The gene discussed is HIF1A; the disease is acute myeloid leukemia.